drugset / Trial / NCT01015586

Treatment of Alcohol Dependence and Comorbid Bipolar Disorder

NCT01015586

RandomizedParallel-groupDouble-blindTreatment

Summary

The study will determine if individuals with co-occurring bipolar disorder and alcohol dependence report reduced alcohol consumption, improvement in mood symptoms, and cognitive performance if treated with lamotrigine plus their usual mood stabilizing medications relative to subjects treated with placebo plus usual mood stabilizing medications over a 16 week period.

Timeline

Start
2010-02
Primary completion
2014-05
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Lamotrigine Small molecule 200 mg